Cell and Gene Therapy: Transforming Lives and Treatments

Description

Cell and gene therapies are rapidly transforming medical care and treatments. These processes use modified cells or cellular matter to treat, prevent or cure serious health issues such as cancer, genetic disorders, immunodeficiencies, and rare diseases.

The Maryland Stem Cell Research Fund has invested over $170 million in Maryland to support this industry and accelerate cures.

This panel, hosted by Johns Hopkins Technology Ventures, will discuss the technologies themselves as well as their applications. Panelists will also explore on the impact of these advances on human life. This panel is designed to appeal both to those who work in this space and those who want to learn more about it.

Panelists:

• Amritha Jaishankar, PhD, executive director, Maryland Stem Cell Research Fund (moderator)
• Vered Caplan, chief executive officer, Orgenesis, Inc.
• Darryl L. Carter, MD, venture advisor, University of Maryland, Baltimore, co-founder, Otter Imuno-Oncology, LLC